Maxeeze Effervescent Tablets
*Company:
Zentiva Pharma UK LimitedStatus:
UpdatedLegal Category:
Product subject to medical prescription which may be renewed (B)Active Ingredient(s):
*Additional information is available within the SPC or upon request to the company
Updated on 24 June 2026
File name
For Med IE PIL common Maxeeze 500-30-8MG TABEF IE.pdf
Reasons for updating
- Change to section 2 - interactions with other medicines, food or drink
Updated on 24 June 2026
File name
Maxeeze SmPC clean 15-02-2026.pdf
Reasons for updating
- Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
Legal category:Product subject to medical prescription which may be renewed (B)
Free text change information supplied by the pharmaceutical company
Concomitant administration of codeine with anticholinergics or medications with anticholinergic activity (e.g. tricyclic antidepressants, antihistamines, antipsychotics, muscle relaxants, anti-Parkinson drugs) may result in increased anticholinergic adverse effects.
Updated on 27 June 2025
File name
PIL_1701-016-001_clean_Maxeeze.pdf
Reasons for updating
- New PIL for new product
Updated on 27 June 2025
File name
SPC_1701-016-001_clean_Maxeeze.pdf
Reasons for updating
- New SPC for new product
Legal category:Product subject to medical prescription which may be renewed (B)
Zentiva Pharma UK Limited
Address:
First Floor, Andrews House, College Road, Guildford, GU1 4QB, UKMedInfo@zentiva.comTelephone:
+353 818 882 243Medical Information Direct Line:
+353 818 882 243 ,